title: Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G.
abstract: OBJECTIVE
  The purpose of this study was to compare the ability of intravenous immunoglobulin (IVIg), intralipid and soluble human leukocyte antigen (sHLA)-G to suppress natural killer (NK) cell cytotoxicity in an in vitro assay.
  
  
  METHODS
  Blood samples taken from 275 women experiencing reproductive failure were analyzed for NK cytotoxicity and the suppression of NK cytotoxicity by IVIg 4 and 2 mg/mL (n = 275), intralipid 18 and 9 mg/mL (n = 275) and sHLA-G 70 and 35 ng/mL (n = 50) using immunofluorescent labeled K562 cells as targets and flow cytometry.
  
  
  RESULTS
  Natural killer cytotoxicity was suppressed in all samples. Among patients with normal NK cell activity, IVIg suppressed NK cytotoxicity by 44.9 +/- 8.1%, intralipid suppressed NK killing by 45.2 +/- 8.3% and sHLA-G suppressed by 49.0 +/- 9.2%. When specimens with abnormal NK activity were observed for suppression of cytotoxicity, IVIg suppressed by 38.9 +/- 5.4%, intralipid suppressed by 39.8 +/- 6.2% and sHLA-G suppressed by 39.9 +/- 5.0%.
  
  
  CONCLUSIONS
  Intravenous immunoglobulin, intralipid and sHLA-G suppressed NK cell cytotoxicity with equal efficacy in an in vitro assay.
authors.affiliation: Millenova Immunology Laboratories, Chicago, IL 60611, USA. rgroussev@yahoo.com
authors.forename: Roumen G
authors.initials: RG
authors.lastname: Roussev
authors.forename: Siu Chui
authors.initials: SC
authors.lastname: Ng
authors.forename: Carolyn B
authors.initials: CB
authors.lastname: Coulam
mesh_terms: D000026:Abortion, Habitual / Q000276:immunology / Q000517:prevention & control*; D002478:Cells, Cultured; D005217:Fat Emulsions, Intravenous / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D005434:Flow Cytometry; D005455:Fluorescent Antibody Technique; D006680:HLA Antigens / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology*; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000276:immunology / Q000378:metabolism / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000276:immunology* / Q000378:metabolism; D011247:Pregnancy
chemical_list: D005217:Fat Emulsions, Intravenous; D006680:HLA Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I; D016756:Immunoglobulins, Intravenous